Healthcare Was Built to Treat. This Fund Was Built to Heal.

Key Takeaways

• Veracor Capital has formally launched the Kure Health Ecosystem Fund, a $250 million growth equity vehicle targeting outcomes-based healthcare.
• The fund is built on Signal-Based Medicine, a 20-year validated clinical methodology developed by founder and Marine veteran Kenton Gray.
• U.S. healthcare spending has reached $5.3 trillion annually while chronic disease worsens, creating a structural gap that the fund is positioned to fill.
• Global healthcare private equity deal value reached $95 billion in 2024, with outcomes-based care capturing the fastest-growing share of institutional capital.
• The fund is available to accredited investors through four structures, with a minimum investment of $250,000 under Regulation D 506(c).
• As a verified veteran-owned business, Veracor Capital holds federal procurement certifications that give portfolio companies a distribution advantage competing funds cannot replicate.

Veracor Capital Launches Kure Health Ecosystem Fund to Transform Patient Care

There is a moment in every industry when someone stops working within a broken system and decides to build a better one. In healthcare, that moment has arrived. The vehicle is the Kure Health Ecosystem Fund.

Veracor Capital, a veteran-owned healthcare private equity firm based in Los Angeles, has formally launched its $250 million flagship growth equity fund. For investors who have been watching the healthcare sector struggle to deliver on its promises, this launch deserves close attention. For more information, visit vhttps://veracorcapital.com/

The Problem No One In Healthcare Wants to Admit

The United States spends $5.3 trillion on healthcare every year. That is 18% of the entire American economy. And yet chronic disease is getting worse, not better. Patients are getting younger, sicker, and more dependent on a system that profits from keeping them that way.

This is not a broken system. It is a system working exactly as designed.

Most healthcare companies generate revenue from ongoing treatment. The longer a patient stays sick, the more revenue flows. That model has dominated healthcare investment for decades. And it has produced the most expensive, least effective chronic care outcomes in the developed world.

The Kure Health Ecosystem Fund was built on a completely different premise.

What Signal-Based Medicine Changes

Founder Kenton Gray spent 20 years building healthcare companies before he launched Veracor Capital. What he identified over those two decades is both simple and significant: chronic disease does not begin as disease. It begins as disruption in the body's own biological signaling systems, the biochemical and physiological communication networks that govern everything from cellular repair to immune response to hormonal balance.

Signal-Based Medicine, the clinical methodology at the core of the fund, works by identifying and correcting that disruption at its source. Not managing symptoms. Not creating dependency. Restoring function and producing lasting outcomes.

This matters to investors for one straightforward reason: companies that actually heal patients generate a fundamentally different financial profile than companies that treat them indefinitely. Higher patient lifetime value. Lower regulatory and litigation risk. Growth driven by referral rather than advertising spend. In a market actively moving toward outcomes-based care, that profile commands a premium.

Why This Fund, Why Now

Global healthcare private equity deal value reached $95 billion in 2024. Consumer health, clinical AI, and outcomes-based care captured the fastest-growing share of that capital. The mass migration of physicians from institutional medicine to cash-pay private practice, combined with a consumer population actively reclaiming control of their own health, has created the largest category-creation opportunity in healthcare in a generation.

The Kure Health Ecosystem Fund is positioned at the center of that shift. It invests exclusively in companies operating within or directly aligned with the Kure Health ecosystem. That ecosystem is built around Signal-Based Medicine, the KureOS signal mapping platform, and Signal Science, the clinical language that standardizes care across every practitioner in the network. This is not a thematic fund casting a wide net across healthcare. It is a vertically integrated capital vehicle for a proprietary ecosystem that already exists, already operates, and is already generating revenue.

That distinction matters. Most funds raise capital and then search for deals. Kenton Gray spent 20 years building the companies first. The fund was created to scale what already works.

To learn more about the Kure Health Ecosystem Fund or to begin the qualification process, visit veracorcapital.com/funds/healthcare-impact.

The Veteran Advantage

19 million U.S. veterans represent a segment with above-average healthcare expenditure and deep trust in veteran-led organizations. That loyalty gives the fund a structural distribution advantage that no conventionally managed competitor can replicate.

How Investors Can Participate

The Kure Health Ecosystem Fund offers four access structures for qualified investors:

Standard LP interest, open to accredited investors at a $250,000 minimum. Co-investment via SPV on a deal-by-deal basis for qualified purchasers. Direct equity or structured debt into individual portfolio companies for institutional and family office investors. Fund co-sponsorship for institutional partners seeking a lead investor structure.

For investors who have spent years watching healthcare funds chase the same tired model, the Kure Health Ecosystem Fund represents something genuinely different: a capital vehicle built not to profit from patients who never recover, but from patients who do.

That is a thesis worth examining.

To learn more about the Kure Health Ecosystem Fund or to begin the qualification process, visit https://veracorcapital.com/funds/healthcare-impact

Media Contact: Barbara Drady barbara@veracorgroup.com

Veracor Capital is a wholly owner subsidiary of Veragroup Group LL

The Kure Health Ecosystem Fund is offered exclusively to accredited investors under Regulation D, Rule 506(c). This is not an offer to sell securities. Forward-looking statements are based on assumptions that may not be realized.

Veracor Capital
City: Miami
Address: 1395 Brickell Avenue
Website: https://veracorcapital.com/